Literature DB >> 25572340

Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.

Christian Carpéné1, Mathilde Bizou, Karine Tréguer, Mounia Hasnaoui, Sandra Grès.   

Abstract

Glitazones are peroxisome proliferator-activated receptor gamma (PPARγ) agonists widely used as antidiabetic drugs also known as thiazolidinediones. Most of them exert other effects such as anti-inflammatory actions via mechanisms supposed to be independent from PPARγ activation (e.g., decreased plasma monocyte chemoattractant protein-1 (MCP-1) levels). Recently, pioglitazone has been shown to inhibit the B form of monoamine oxidase (MAO) in mouse, while rosiglitazone and troglitazone were described as non-covalent inhibitors of both human MAO A and MAO B. Since molecules interacting with MAO might also inhibit semicarbazide-sensitive amine oxidase (SSAO), known as vascular adhesion protein-1 (VAP-1), and since VAP-1/SSAO inhibitors exhibit anti-inflammatory activity, our aim was to elucidate whether VAP-1/SSAO inhibition could be a mechanism involved in the anti-inflammatory behaviour of glitazones. To this aim, MAO and SSAO activities were measured in human subcutaneous adipose tissue biopsies obtained from overweight women undergoing plastic surgery. The production of hydrogen peroxide, an end-product of amine oxidase activity, was determined in tissue homogenates using a fluorometric method. The oxidation of 1 mM tyramine was inhibited by pargyline and almost resistant to semicarbazide, therefore predominantly MAO-dependent. Rosiglitazone was more potent than pioglitazone in inhibiting tyramine oxidation. By contrast, benzylamine oxidation was only abolished by semicarbazide: hence SSAO-mediated. Pioglitazone hampered SSAO activity only when tested at 1 mM while rosiglitazone was inefficient. However, rosiglitazone exhibited anti-inflammatory activity in human adipocytes by limiting MCP-1 expression. Our observations rule out any involvement of VAP-1/SSAO inhibition and subsequent limitation of leukocyte extravasation in the anti-inflammatory action of glitazones.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25572340     DOI: 10.1007/s13105-014-0379-3

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  40 in total

1.  Thiazolidinediones are partial agonists for the glucocorticoid receptor.

Authors:  L Matthews; A Berry; M Tersigni; F D'Acquisto; A Ianaro; D Ray
Journal:  Endocrinology       Date:  2008-09-18       Impact factor: 4.736

2.  The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.

Authors:  Sandy Bour; María-Carmen Iglesias-Osma; Luc Marti; Piedad Duro; María-José Garcia-Barrado; Maria-Francisca Pastor; Danielle Prévot; Virgile Visentin; Philippe Valet; Julio Moratinos; Christian Carpéné
Journal:  Eur J Pharmacol       Date:  2006-09-23       Impact factor: 4.432

3.  Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B.

Authors:  Richard T Carroll; Dean E Dluzen; Hilary Stinnett; Prabha S Awale; Max O Funk; Werner J Geldenhuys
Journal:  Bioorg Med Chem Lett       Date:  2011-06-21       Impact factor: 2.823

4.  A peroxidase-coupled continuous absorbance plate-reader assay for flavin monoamine oxidases, copper-containing amine oxidases and related enzymes.

Authors:  Andrew Holt; Monica M Palcic
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice.

Authors:  Zsuzsa Iffiú-Soltész; Josep Mercader; Danielle Daviaud; Jérémie Boucher; Christian Carpéné
Journal:  J Neural Transm (Vienna)       Date:  2011-02-05       Impact factor: 3.575

6.  Effects of peroxidase substrates on the Amplex red/peroxidase assay: antioxidant properties of anthracyclines.

Authors:  Krzysztof J Reszka; Brett A Wagner; C Patrick Burns; Bradley E Britigan
Journal:  Anal Biochem       Date:  2005-07-15       Impact factor: 3.365

7.  Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.

Authors:  Guang Wang; Jinru Wei; Youfei Guan; Nan Jin; Jieming Mao; Xian Wang
Journal:  Metabolism       Date:  2005-05       Impact factor: 8.694

8.  Inhibition of semicarbazide-sensitive amine oxidases decreases lymphocyte infiltration in the early phases of rat liver allograft rejection.

Authors:  T Martelius; M Salmi; L Krogerus; R Loginov; M Schoultz; M Karikoski; M Miiluniemi; A Soots; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Oct-Dec       Impact factor: 3.219

9.  Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.

Authors:  C Carpéné; V Abello; Z Iffiú-Soltész; N Mercier; Bruno Fève; P Valet
Journal:  Pharmacol Res       Date:  2008-04-24       Impact factor: 7.658

10.  Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells.

Authors:  Sandra Grès; Sarah Canteiro; Josep Mercader; Christian Carpéné
Journal:  Mol Nutr Food Res       Date:  2013-02-06       Impact factor: 5.914

View more
  4 in total

1.  Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.

Authors:  Christian Carpéné; Francisco Les; Mounia Hasnaoui; Simon Biron; Picard Marceau; Denis Richard; Jean Galitzky; Denis R Joanisse; Pascale Mauriège
Journal:  J Physiol Biochem       Date:  2016-10-21       Impact factor: 4.158

2.  Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.

Authors:  E Hijona; L Aguirre; P Pérez-Matute; M J Villanueva-Millán; A Mosqueda-Solis; M Hasnaoui; F Nepveu; J M Senard; L Bujanda; L Aldámiz-Echevarría; M Llarena; F Andrade; P Perio; F Leboulanger; L Hijona; J M Arbones-Mainar; M P Portillo; C Carpéné
Journal:  J Physiol Biochem       Date:  2016-01-20       Impact factor: 4.158

3.  High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in mice.

Authors:  Christian Carpéné; Stéphane Schaak; Céline Guilbeau-Frugier; Josep Mercader; Jeanne Mialet-Perez
Journal:  J Physiol Biochem       Date:  2015-12-03       Impact factor: 4.158

4.  Dietary Phenolic Compounds Interfere with the Fate of Hydrogen Peroxide in Human Adipose Tissue but Do Not Directly Inhibit Primary Amine Oxidase Activity.

Authors:  Christian Carpéné; Mounia Hasnaoui; Balázs Balogh; Peter Matyus; Alfredo Fernández-Quintela; Víctor Rodríguez; Josep Mercader; Maria P Portillo
Journal:  Oxid Med Cell Longev       Date:  2016-01-05       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.